scholarly article | Q13442814 |
P50 | author | Ralph H. Hruban | Q21063634 |
Christine A Iacobuzio-Donahue | Q58327762 | ||
P2093 | author name string | Scott E Kern | |
Byungwoo Ryu | |||
P2860 | cites work | Genes expressed in human tumor endothelium | Q24290105 |
Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization | Q24670568 | ||
Serial analysis of gene expression | Q27860777 | ||
Effects of estrogen on global gene expression: identification of novel targets of estrogen action | Q28138141 | ||
Apolipoprotein D | Q28142696 | ||
The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor | Q28214235 | ||
Gene expression profiles in normal and cancer cells | Q29619943 | ||
A public database for gene expression in human cancers | Q30809646 | ||
Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer | Q31833417 | ||
In situ hybridization-theory and practice | Q33769365 | ||
Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades | Q33989863 | ||
The integration of cell adhesion with gene expression: the role of beta-catenin. | Q34084669 | ||
Modulation of endothelial cell survival by an inhibitor of angiogenesis thrombospondin-1: a dynamic balance. | Q34146400 | ||
The pattern of gene expression in human CD15+ myeloid progenitor cells | Q34728677 | ||
High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer | Q35759154 | ||
Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity | Q35810149 | ||
Extracellular matrix regulates expression of the TGF-beta 1 gene | Q36232179 | ||
Effect on DNA transcription of nucleotide sequences upstream to T7 promoter | Q39717466 | ||
Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. | Q40716089 | ||
Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells | Q60609535 | ||
Allelotype of pancreatic adenocarcinoma | Q72386220 | ||
Selective upregulated expression of the alpha2-macroglobulin signaling receptor in highly metastatic 1-LN prostate carcinoma cells | Q73244884 | ||
Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas | Q73339752 | ||
Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma | Q73828612 | ||
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis | Q74067195 | ||
Identifying markers for pancreatic cancer by gene expression analysis | Q74263354 | ||
Serial analysis of gene expression in non-small cell lung cancer | Q77726399 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pancreatic carcinoma | Q18556536 |
P304 | page(s) | 91-99 | |
P577 | publication date | 2002-01-01 | |
P1433 | published in | The American Journal of Pathology | Q4744259 |
P1476 | title | Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion | |
P478 | volume | 160 |
Q34259999 | AKI after conditional and kidney-specific knockdown of stanniocalcin-1. |
Q37497757 | Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma |
Q38274043 | Adenocarcinoma of the pancreas |
Q33307131 | Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells |
Q92861943 | Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer |
Q37255331 | Application of HB17, an Arabidopsis class II homeodomain-leucine zipper transcription factor, to regulate chloroplast number and photosynthetic capacity |
Q37970379 | Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression |
Q28834154 | Bioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkers |
Q34569128 | Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation |
Q35017547 | CD109 Overexpression in Pancreatic Cancer Identified by Cell-Surface Glycoprotein Capture |
Q37049583 | CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer |
Q64889128 | Cancer-Associated Fibroblasts Enhance Survival and Progression of the Aggressive Pancreatic Tumor Via FGF-2 and CXCL8. |
Q34431614 | Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma |
Q80353444 | Contrast-enhanced sonography of pancreatic carcinoma: correlations with pathological findings |
Q37197412 | Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma |
Q37780799 | Desmoplasia: not always a bad thing. |
Q28534618 | Development and histopathological characterization of tumorgraft models of pancreatic ductal adenocarcinoma |
Q38311218 | Differential expression of insulin-like growth factor binding protein-5 in pancreatic adenocarcinomas: identification using DNA microarray |
Q31048088 | Discovery of novel tumor markers of pancreatic cancer using global gene expression technology |
Q54334426 | Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer. |
Q34246014 | Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma |
Q57296541 | EUS fine-needle pancreatic core biopsy can determine eligibility for tumor-agnostic immunotherapy |
Q28185685 | Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays |
Q47585043 | Expression and characterization of murine hevin (SC1), a member of the SPARC family of matricellular proteins |
Q48807684 | Expression of p75NTR in fetal brain and medulloblastomas: evidence of a precursor cell marker and its persistence in neoplasia |
Q42475774 | Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma |
Q37711618 | Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction. |
Q34768641 | Focus on pancreas cancer |
Q35115628 | Gene Expression in Neoplasms of the Pancreas: Applications to Diagnostic Pathology |
Q31156199 | Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma |
Q30830632 | Gene expression patterns in pancreatic tumors, cells and tissues |
Q24646856 | Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma |
Q36032931 | Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications |
Q34589293 | Genetics and pathology of pancreatic cancer |
Q47340801 | Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. |
Q35791572 | Identification of novel cellular targets in biliary tract cancers using global gene expression technology |
Q34005862 | Increased circulating cell signalling phosphoproteins in sera are useful for the detection of pancreatic cancer |
Q35587710 | Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma |
Q47950548 | Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma |
Q64095024 | Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers |
Q35839019 | Interplay between β1-integrin and Rho signaling regulates differential scattering and motility of pancreatic cancer cells by snail and Slug proteins |
Q81635341 | Is desmoplasia a protective factor for survival in patients with colorectal carcinoma? |
Q26766065 | Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells |
Q37725460 | Loss of MTSS1 results in increased metastatic potential in pancreatic cancer |
Q35388201 | MT1-MMP cooperates with Kras(G12D) to promote pancreatic fibrosis through increased TGF-β signaling |
Q35123674 | MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers |
Q73614651 | Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis |
Q81068282 | Osteopontin expression in ductal adenocarcinomas and undifferentiated carcinomas of the pancreas |
Q36695742 | Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer |
Q24628890 | Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells |
Q24170403 | Pancreatic cancer |
Q30490247 | Pancreatic cancer. |
Q33356654 | Preoperative evaluation of pancreatic adenocarcinoma |
Q37448935 | Prognostic signature for pancreatic cancer: are we close? |
Q36173905 | Reg-II is an exocrine pancreas injury-response product that is up-regulated by keratin absence or mutation |
Q27012580 | Regulation of pancreatic function by connective tissue growth factor (CTGF, CCN2) |
Q35170428 | Role of tissue stroma in cancer cell invasion |
Q36419981 | SAGE and related approaches for cancer target identification |
Q27027759 | SIBLINGs and SPARC families: their emerging roles in pancreatic cancer |
Q35813979 | SPARC and tumor growth: where the seed meets the soil? |
Q73767192 | SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions |
Q36723725 | Stromal biology of pancreatic cancer |
Q36143628 | Stromal metalloproteinase-9 is essential to angiogenesis and progressive growth of orthotopic human pancreatic cancer in parabiont nude mice |
Q39312912 | Surgical strategies and novel therapies for locally advanced pancreatic cancer |
Q28299932 | The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells |
Q36841980 | The fibromatosis signature defines a robust stromal response in breast carcinoma |
Q53673930 | The gene expression profile of extraskeletal myxoid chondrosarcoma. |
Q33404355 | The isolation and identification of apolipoprotein C-I in hormone-refractory prostate cancer using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry |
Q34330564 | The macrophage colony-stimulating factor 1 response signature in breast carcinoma |
Q35102879 | The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status |
Q33275720 | Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer |
Q58699630 | Typing of pancreatic cancer-associated fibroblasts identifies different subpopulations |
Search more.